High Level of Rheumatoid Factor is Associated with Hepatitis B Viremia in Patients with Chronic Hepatitis B

Hepatitis viruses are causative agents for chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. However these viruses are also associated with lymphoproliferative disorders (LPDs), such as essential mixed cryoglobulinemia and B-cell non-Hodgkin’s lymphoma. Indeed, hepatitis C virus infection has been confirmed to be associated with LPDs, but the pathogenic mechanism remains unclear. In this study, we investigated the relationship between hepatitis B virus (HBV) infection and LPDs in 84 patients with chronic hepatitis B (CH-B). LPD markers, such as cryoglobulinemia, high levels of rheumatoid factor (RF), hypocomplementemia, and B cell clonality, were measured and analyzed along with viral factors. Results showed that high levels of RF were observed in 39.5% of patients with CH-B. These high RF levels were not associated with abnormal levels of other LPD markers, but only with the presence of HBV DNA in the sera of these patients. Undergoing therapy with nucleotide analogues was also associated with high RF. In two patients with CH-B, decreasing levels of RF were observed during antiviral therapy. In conclusion, high RF levels are associated with HBV viremia in patients with CH-B. HBV infection also plays an important role in the genesis of LPDs in patients with viral hepatitis..

[1]  K. Morikawa,et al.  Lymphotropic hepatitis C virus has an interferon‐resistant phenotype , 2012, Journal of viral hepatitis.

[2]  P. Pugnale,et al.  Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections. , 2011, Journal of hepatology.

[3]  Takayoshi Ito,et al.  Infection of B cells with hepatitis C virus for the development of lymphoproliferative disorders in patients with chronic hepatitis C , 2009, Journal of medical virology.

[4]  A. Zignego,et al.  HBV and HCV chronic infection: autoimmune manifestations and lymphoproliferation. , 2008, Autoimmunity reviews.

[5]  Y. Shoenfeld,et al.  Hepatitis B Virus (HBV) and Autoimmune Disease , 2008, Clinical reviews in allergy & immunology.

[6]  S. Pol,et al.  Hepatitis B virus genotypes and extrahepatic manifestations. , 2005, Journal of hepatology.

[7]  S. Takai,et al.  Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy , 2005, European journal of haematology.

[8]  M. Newkirk Rheumatoid factors: what do they tell us? , 2002, The Journal of rheumatology.

[9]  C. Bréchot,et al.  Extrahepatic manifestations of HCV infection: facts and controversies. , 1999, Journal of hepatology.

[10]  T. Delbanco,et al.  The rheumatoid factor: an analysis of clinical utility. , 1991, The American journal of medicine.

[11]  G. Rodnan,et al.  Serum Anti-γ-Globulin and Antinuclear Factors in the Aged , 1967 .

[12]  J. Singer,et al.  STUDIES OF THE INCIDENCE AND SIGNIFICANCE OF ANTI-GAMMA GLOBULIN FACTORS IN THE AGING. , 1965, Arthritis and rheumatism.

[13]  K. Lankarani Extrahepatic manifestations of chronic hepatitis C. , 2009 .

[14]  S. Pileri,et al.  Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[15]  P. Cacoub,et al.  Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. , 1999, Arthritis and rheumatism.

[16]  G. Rodnan,et al.  Serum anti-gamma-globulin and antinuclear factors in the aged. , 1967, JAMA.